PDS5B and glioma: HOXA-AS3 expression was also verified as an independent prognostic predictor in various disorders, including hepatocellular carcinoma, glioma [26, 27], oral squamous cell carcinoma, and gastric cancer, using univariate and multivariate Cox regression analyses [23–25].